VGLS — VG Life Sciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $2.11m
- $6.11m
Annual balance sheet for VG Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | C2011 December 31st | R2012 December 31st | 2013 December 31st | 2014 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PRESS | ARS | 10-Q | 10-Q | 10-K |
Standards: | — | — | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.007 | 0.006 | 0.006 | 0.714 | 0.034 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.016 | 0.009 | 0.006 | 0.789 | 0.246 |
Net Property, Plant And Equipment | 0 | — | 0 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 3.1 | 3.09 | 1.08 | 1.87 | 1.32 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.14 | 2.81 | 5.28 | 6.33 | 5.83 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 5.11 | 4.15 | 5.98 | 7.03 | 6.49 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.01 | -1.06 | -4.9 | -5.17 | -5.17 |
Total Liabilities & Shareholders' Equity | 3.1 | 3.09 | 1.08 | 1.87 | 1.32 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |